Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ
Holding JAZZ?
Track your performance easily

Jazz Pharmaceuticals (JAZZ) Financial Statements

1,489 Followers

Jazz Pharmaceuticals Financial Overview

Jazz Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $6.942; its P/E ratio is 17.15; Jazz Pharmaceuticals is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $5.92. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 1.05B$ 1.02B$ 901.98M$ 1.01B$ 972.14M
Gross Profit$ 1.05B$ 1.02B$ 901.98M$ 904.69M$ 869.99M
EBIT$ 200.52M$ 137.91M$ 92.54M-$ 171.01M
EBITDA$ 365.75M$ 300.95M$ 255.92M-$ 333.57M
Net Income Common Stockholders$ 215.06M$ 168.57M$ -14.62M$ 94.15M$ 146.82M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.22B$ 1.36B$ 1.44B$ 1.51B$ 1.34B
Total Assets$ 12.26B$ 11.36B$ 11.33B$ 11.39B$ 11.20B
Total Debt$ 6.18B$ 5.77B$ 5.77B$ 5.77B$ 5.78B
Net Debt$ 3.96B$ 4.42B$ 4.32B$ 4.27B$ 4.44B
Total Liabilities$ 8.09B$ 7.60B$ 7.63B$ 7.66B$ 7.71B
Stockholders Equity$ 4.17B$ 3.76B$ 3.70B$ 3.74B$ 3.49B
Cash Flow-
Free Cash Flow$ 387.96M$ 324.26M$ 260.32M-$ 302.90M
Operating Cash Flow$ 398.75M$ 331.35M$ 267.23M$ 167.34M$ 307.19M
Investing Cash Flow$ 214.09M$ -257.09M$ -271.90M$ 101.80M$ -174.30M
Financing Cash Flow$ 246.43M$ -161.09M$ -56.55M$ -100.31M$ -78.49M
Currency in USD

Jazz Pharmaceuticals Earnings and Revenue History

Jazz Pharmaceuticals Debt to Assets

Jazz Pharmaceuticals Cash Flow

Jazz Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis